ZFTA–RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial EpendymomaAmir Arabzade, Stephen C. Mack, Austin J. Stuckert et al.|Cancer Discovery|2021Cited by 90
A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumorsBrian Golbourn, James T. Rutka|Neuro-Oncology|2024Cited by 5
Table S1 from ZFTA–RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial EpendymomaAmir Arabzade, Stephen C. Mack, Yanhua Zhao et al.|Unknown|2023Cited by 0